Calcium Regulation of NF-kB Activation in Lymphocytes
淋巴细胞中 NF-kB 激活的钙调节
基本信息
- 批准号:9352513
- 负责人:
- 金额:$ 57.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-23 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAntigen ReceptorsAntigensAvidityBiochemicalBiochemical GeneticsCD28 AntigensCD28 geneCD8B1 geneCalciumCalcium SignalingCalcium ionCellsCompetenceCustomDataDefectDevelopmentDiseaseExhibitsFrequenciesFutureGene ExpressionGenerationsGenesGenetic TranscriptionImageImmuneImmune responseImmunityIndividualLifeLigationLinkLymphocyteMass Spectrum AnalysisMeasurementMediatingModificationMolecularMusNF-kappa BNatureNuclearPatternPerfusionPhenotypePhosphorylationPhysiologic pulsePlayProteinsPublic HealthPublicationsRegulationReporterRoleSTIM1 geneSignal TransductionSpecificitySystemT-LymphocyteTNF geneTimeTranscriptional RegulationVariantWidthbasedesignin vivoinnovationinsightlive cell imagingnovelp65preventprogenitorprogramsreceptortherapeutic targetthymocytetooltranscriptome sequencing
项目摘要
PROJECT SUMMARY
Antigen receptor-induced calcium (Ca2+) signals regulate lymphocyte development and effector functions, but
major gaps persist in our understanding of the dynamics of these signals, their transcriptional consequences
and how cell fates are governed by distinct receptor-induced Ca2+ waveforms. Supporting data in this
application and a pending publication reveal entirely novel and indispensable mechanisms by which Ca2+
specifically tunes TCR, but not TNF, induced NF-κB p65 and c-Rel activation. Our findings that p65 and c-Rel
phosphorylation may serve as Ca2+ dependent checkpoints provide a framework for understanding how distinct
patterns of Ca2+ signaling in vivo control the transcriptional programs that drive lymphocyte development and
function. Central to TCR-induced Ca2+ entry are the ER transmembrane Ca2+ sensing STIM1 and STIM2
proteins, and the STIM-activated Ca2+ channel CRAC/Orai. Mice whose T cell progenitors lack STIM1/2 exhibit
a selective defect in nTreg induction and the immune phenotype of these mice is virtually indistinguishable
from that of mice with a c-Rel deficiency. Moreover, as nTreg development is driven by CD28 costimulation in
conjunction with high affinity/avidity TCR ligation, and we have previously shown that CD28 biases this
deterministic signal toward high amplitude Ca2+ spikes over a range of antigen receptor ligation avidities, we
hypothesize that CD28 tuning of TCR induced Ca2+ dynamics generates a quantitatively unique waveform that
drives c-Rel-dependent nTreg generation. Based on our pending publication and new supporting data, we
hypothesize that TCR induced Ca2+-dependent phosphorylation of individual p65 and c-Rel Ser/Thr residues is
regulated by distinct Ca2+ thresholds and waveforms, thereby providing a mechanism by which quantitatively
distinct Ca2+ signals differentially regulate NF-κB-dependent gene expression controlling lymphocyte
development and functions. To address this hypothesis, we will: 1) Define the nature and function of Ca2+-
regulated phosphorylation of p65 and c-Rel, 2) determine how Ca2+ controls NF-κB-driven transcriptional
specificity, and 3) define the Ca2+ dependent mechanisms of thymic nTreg development. We will use a custom
built “Ca2+ clamp” perfusion system to impose variations in the Ca2+ amplitude, pulse width, frequency, and
total input to define how Ca2+ waveforms control sequential checkpoints in NF-B activation and long-term
imaging measurements utilizing a novel genetically encoded Ca2+ indicator (GCaMP6f) to determine how
antigen-induced Ca2+ signals contribute to the regulation of nTreg development. The combined expertise of the
team, the systems and approaches, and the quantitative tools developed for these studies will provide a new
and detailed mechanistic understanding of how calcium dependent phosphorylation regulates transcriptional
specificity of NF-B in T cells and will provide insights into strategies and therapeutic targets for enhancing
insufficient, suppressing auto-reactive, or redirecting inappropriate immune responses.
项目摘要
抗原受体诱导的钙(CA2+)信号调节淋巴细胞发育和效应子功能,但
主要差距仍然存在我们对这些信号的动态的理解,以及它们的转录后果
以及细胞命运如何受不同接收器诱导的Ca2+波形的控制。支持数据
应用和未决的出版物揭示了CA2+的完全新颖和必不可少的机制
调谐TCR,但不是TNF诱导NF-κBp65和C-Rel激活。我们的发现P65和C-REL
磷酸化可以用作Ca2+依赖性检查点,提供了一个框架,以了解如何不同
体内Ca2+信号传导的模式控制驱动淋巴细胞发育和的转录程序
功能。 TCR诱导的Ca2+进入的中心是ER跨膜Ca2+传感STIM1和STIM2
蛋白质和刺激激活的Ca2+通道CRAC/ORAI。 T细胞祖细胞缺乏STIM1/2的小鼠
NTREG诱导和这些小鼠的免疫表型的选择性缺陷实际上是无法区分的
来自C-REL缺乏的小鼠。此外,随着NTREG的开发是由CD28共刺激驱动的
与高亲和力/亲和力TCR连接的结合,我们先前已经表明CD28偏向于此
在一系列抗原受体连接狂热范围内,针对高放大器Ca2+尖峰的确定性信号,我们
假设TCR诱导的Ca2+动力学的CD28调整会产生一个定量独特的波形
驱动依赖C-REL的NTREG生成。基于我们未决的出版物和新的支持数据,我们
假设TCR诱导的Ca2+依赖性的p65和C-Rel Ser/Thr残基的辉磷酸化为
由不同的Ca2+阈值和波形调节,从而提供了一种定量的机制
不同的Ca2+信号对控制淋巴细胞的NF-κB依赖基因表达的调节不同
发展和功能。为了解决这一假设,我们将:1)定义Ca2+ - 的性质和功能
p65和c-Rel的调节磷酸化,2)确定CA2+如何控制NF-κB驱动的转录。
特异性和3)定义胸腺NTREG发育的Ca2+依赖性机制。我们将使用自定义
构建的“ Ca2+夹具”灌注系统以在CA2+放大器,脉冲宽度,频率和
总输入以定义CA2+波形如何控制NF-B激活中的顺序检查点
利用新型遗传编码的Ca2+指标(GCAMP6F)的成像测量结果来确定如何
抗原诱导的Ca2+信号有助于调节NTREG发育。联合专家
团队,系统和方法以及为这些研究开发的定量工具将提供新的
以及详细的机械理解如何依赖钙的磷酸化调节转录
NF-B在T细胞中的特异性,并将为增强策略和治疗靶标提供见解
不足,抑制自动反应性或重定向不当免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE D FREEDMAN其他文献
BRUCE D FREEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE D FREEDMAN', 18)}}的其他基金
Building Enhanced Capability for the PennVet Multiphoton Core
为 PennVet 多光子核心构建增强功能
- 批准号:
9075603 - 财政年份:2016
- 资助金额:
$ 57.6万 - 项目类别:
FLIM system, resonant scanner, and UV laser for 2 photon microscope
用于 2 光子显微镜的 FLIM 系统、共振扫描仪和紫外激光器
- 批准号:
7794472 - 财政年份:2010
- 资助金额:
$ 57.6万 - 项目类别:
Novel mechanisms of Ca2+ signaling in B lymphocytes
B 淋巴细胞中 Ca2 信号传导的新机制
- 批准号:
6923251 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
Novel Mechanisms of Calcium Signaling in B lymphocytes
B 淋巴细胞钙信号传导的新机制
- 批准号:
8605495 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
Novel mechanisms of Ca2+ signaling in B lymphocytes
B 淋巴细胞中 Ca2 信号传导的新机制
- 批准号:
7339631 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
Novel Mechanisms of Calcium Signaling in B lymphocytes
B 淋巴细胞钙信号传导的新机制
- 批准号:
8211059 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
Novel Mechanisms of Calcium Signaling in B lymphocytes
B 淋巴细胞钙信号传导的新机制
- 批准号:
7887578 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
Novel mechanisms of Ca2+ signaling in B lymphocytes
B 淋巴细胞中 Ca2 信号传导的新机制
- 批准号:
7172920 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
Novel Mechanisms of Calcium Signaling in B lymphocytes
B 淋巴细胞钙信号传导的新机制
- 批准号:
8417768 - 财政年份:2005
- 资助金额:
$ 57.6万 - 项目类别:
相似国自然基金
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 57.6万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 57.6万 - 项目类别:
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
HORMAD 特异性 TGF-β 耐药性记忆 T 细胞用于治疗胃食管癌患者
- 批准号:
10731407 - 财政年份:2023
- 资助金额:
$ 57.6万 - 项目类别:
Immunoprofiling of Opioid Use Disorder Patients to inform structure-guided design of opioid-specific monoclonal antibodies
阿片类药物使用障碍患者的免疫分析可为阿片类药物特异性单克隆抗体的结构指导设计提供信息
- 批准号:
10751233 - 财政年份:2023
- 资助金额:
$ 57.6万 - 项目类别: